FMmeds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: coverage in all 50 states, which most sellers will not confirm
FMmeds falls below our bar on disclosure. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked July 2026
Vitamin B12 is co-formulated into both the compounded semaglutide and the compounded tirzepatide sold here. No membership charge applies, and the first visit is free unless the patient is approved. Dose strength does not move the price. Commit to 12 months and semaglutide falls to $95/mo, tirzepatide to $145/mo. FMmeds works out of Manhattan Beach, names Manifest Pharmacy of Greer, SC as its 503A partner, and covers all 50 states and DC.
Is FMmeds legit?
Yes. FMmeds is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 7.2/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a FMmeds promo or coupon code?
We know of no promo or coupon code for FMmeds. Its listed price is $225 a month. Coupon sites advertising "FMmeds discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how FMmeds compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to FMmeds
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
FMmeds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $225/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How FMmeds scores
Six columns, each one computed from something FMmeds has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
4.6/10$265/month is 6% above the $250 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
5.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
10.0/10Serves 51 of 50 states.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on FMmeds
Last checked July 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for FMmeds
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with FMmeds involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1FMmeds shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask FMmeds which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes shipping.
- Lowest ongoing monthly price: semaglutide $225, tirzepatide $265. That leaves out membership fees, first-month rates and insurance copays.
- FMmeds serves all 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting FMmeds
- Phone
- (888) 996-8639
- FMmeds offers email support
GLP-1 medications FMmeds offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Standing month-to-month rate. Prepay cadences work out to $129/mo (3-month), $119/mo (6-month) and $95/mo (12-month) — the homepage currently headlines the $95 figure, which is the 12-month prepay equivalent.
Standing month-to-month rate. Prepay cadences work out to $195/mo (3-month), $175/mo (6-month) and $145/mo (12-month) — the homepage headlines $145.
Check the price yourself before you pay
Every figure here was read off FMmeds's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Tirzepatide costs $265 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes shipping
- Serves all 50 states
- We found no FDA warning letters issued to FMmeds
Against it
- Semaglutide costs $225 a month, 22% above the $185 median for compounded semaglutide across the sellers we compare
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What FMmeds charges
FMmeds lists $225/month, flat regardless of dose. Flat dose pricing matters more than it sounds: on a tiered plan the bill grows with the dose, so the figure that got you to sign up is not the one you end up paying.
- Compounded semaglutide: $225/month
- Compounded tirzepatide: $265/month
For compounded tirzepatide, the median across the sellers we compare is $250/month, so FMmeds' $265 lands mid-market. Price is unlikely to be the deciding factor.
HumeCare+ dispenses semaglutide and tirzepatide from $199/month, which makes it the fair comparison to run before you commit here.
What FMmeds dispenses
FMmeds prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality.
Safety and disclosure
FMmeds tells you its price before you start the medical questionnaire, that it treats patients in all 50 states, and that its pharmacy is accredited. We found no FDA warning letters issued to FMmeds. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If FMmeds will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether FMmeds bills your plan before you start.
It fits if
- you want the price to stop moving as your dose climbs
- you need access wherever you live
Our read
FMmeds lands mid-market on price. The catch is disclosure, which is why FMmeds scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you. Eden is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
FMmeds falls below our bar on disclosure. Read the breakdown below before you give it money.
Before you pay FMmeds
Starting at $225 a month. Check today's price, then start the intake.
Where FMmeds is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare FMmeds head to head
The sellers closest to FMmeds on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this FMmeds review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of July 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See FMmeds's current pricing
Plans start at $225 a month. Whether you qualify is a clinician's decision, made after your intake.